angiotensin ii has been researched along with warfarin in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (14.29) | 18.7374 |
1990's | 2 (14.29) | 18.2507 |
2000's | 2 (14.29) | 29.6817 |
2010's | 6 (42.86) | 24.3611 |
2020's | 2 (14.29) | 2.80 |
Authors | Studies |
---|---|
Miller, JH; Smail, GA | 1 |
Bollinger, A | 1 |
Cunningham, DF; O'Connor, B | 1 |
Woo, KT | 1 |
Chen, Q; Chen, XY; Fan, LM; Rao, MR; Wei, EH | 1 |
Liu, WB; Rao, MR; Zhang, XW | 1 |
Kim, MS; Lee, BH; Lee, JH; Mun, J; Oh, KS; Ryu, SY | 1 |
Chen, R; Xie, M; Xue, J | 1 |
Hao, Y; Liu, Y | 1 |
Chen, WQ; Cui, GH; Shen, ZY | 1 |
Fu, B; Ma, X; Mu, C; Su, Y; Yu, F | 1 |
Chen, PP; Cheng, Q; Liu, J; Lu, LM; Miao, NJ; Wang, B; Wang, XX; Wang, YZ; Xie, HY; Xu, D; Xue, H; Yin, F; Yin, JY; Zhang, W; Zhou, L; Zhou, ZL | 1 |
Chen, J; Chen, Y; Fang, L; Gao, H; Li, H; Lin, J; Lv, R; Lyu, L; Wang, W; Xu, F; Yan, T | 1 |
Fukuda, D; Hara, T; Ise, T; Kusunose, K; Matsuura, T; Sata, M; Soeki, T; Tobiume, T; Uematsu, E; Wakatsuki, T; Yagi, S; Yamada, H; Yamaguchi, K | 1 |
1 review(s) available for angiotensin ii and warfarin
Article | Year |
---|---|
Current therapeutic strategies in glomerulonephritis.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Cyclophosphamide; Cyclosporine; Dipyridamole; Glomerulonephritis; Humans; Immunosuppressive Agents; Nephrotic Syndrome; Remission Induction; Steroids; Tacrolimus; Vasodilator Agents; Warfarin | 1999 |
13 other study(ies) available for angiotensin ii and warfarin
Article | Year |
---|---|
Interaction of the enantiomers of warfarin with human serum albumin, peptides and amino acids [proceedings].
Topics: Angiotensin II; Humans; In Vitro Techniques; Pentagastrin; Protein Binding; Stereoisomerism; Tryptophan; Tyrosine; Warfarin | 1977 |
[Internal therapy of peripheral arterial blood circulation disorders].
Topics: Adenosine Triphosphate; Aged; Angiotensin II; Anti-Bacterial Agents; Blood Pressure; Chlorpromazine; Chronic Disease; Collateral Circulation; Coumarins; Epinephrine; Ergot Alkaloids; Exercise Therapy; Femoral Artery; Fibrinolytic Agents; Humans; Infusions, Parenteral; Male; Methoxamine; Nicotinic Acids; Papaverine; Popliteal Artery; Propranolol; Reserpine; Sympatholytics; Sympathomimetics; Thrombosis; Vascular Diseases | 1970 |
A study of prolyl endopeptidase in bovine serum and its relevance to the tissue enzyme.
Topics: Angiotensin II; Animals; Binding, Competitive; Bradykinin; Cattle; Chloromercuribenzoates; Coumarins; Enzyme Inhibitors; Enzyme Stability; Fluorometry; Gonadotropin-Releasing Hormone; Hydrogen-Ion Concentration; Metals; Molecular Weight; Neuropeptides; p-Chloromercuribenzoic Acid; Prolyl Oligopeptidases; Serine Endopeptidases; Substance P; Substrate Specificity | 1998 |
Inhibitory effects of praeruptorin C on cattle aortic smooth muscle cell proliferation.
Topics: Angiotensin II; Animals; Animals, Newborn; Aorta, Thoracic; Cattle; Cell Cycle; Cell Division; Cell Separation; Cells, Cultured; Coumarins; DNA; Drugs, Chinese Herbal; L-Lactate Dehydrogenase; Muscle, Smooth, Vascular | 2002 |
[Effects of praeruptorin C on cell hypertrophy, intracellular [Ca2+]i, nitric oxide and signal transduction in isolated hypertrophied rat smooth muscle cells induced by angiotensin II].
Topics: Angiotensin II; Animals; Aorta; Calcium; Calcium Channel Blockers; Cells, Cultured; Coumarins; Female; Hypertrophy; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nitric Oxide; Rats; Rats, Sprague-Dawley; Signal Transduction | 2002 |
Kamolonol suppresses angiotensin II-induced stress fiber formation and cellular hypertrophy through inhibition of Rho-associated kinase 2 activity.
Topics: Angiotensin II; Animals; Cell Line; Coumarins; Dose-Response Relationship, Drug; Gene Expression Regulation, Enzymologic; Humans; Hypertrophy; Inhibitory Concentration 50; Phosphorylation; Rats; rho-Associated Kinases; Sesquiterpenes; Stress Fibers | 2013 |
Osthole regulates TGF-β1 and MMP-2/9 expressions via activation of PPARα/γ in cultured mouse cardiac fibroblasts stimulated with angiotensin II.
Topics: Angiotensin II; Animals; Cells, Cultured; Coumarins; Fibroblasts; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Myocardium; NF-kappa B; PPAR alpha; PPAR gamma; RNA, Messenger; Transcription Factor RelA; Transforming Growth Factor beta1 | 2013 |
Osthole Alleviates Bleomycin-Induced Pulmonary Fibrosis via Modulating Angiotensin-Converting Enzyme 2/Angiotensin-(1-7) Axis and Decreasing Inflammation Responses in Rats.
Topics: Acute Lung Injury; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Anti-Inflammatory Agents; Bleomycin; Collagen; Coumarins; Cytokines; Edema; Lung; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Pulmonary Fibrosis; Rats, Sprague-Dawley; Transforming Growth Factor beta1 | 2016 |
Urolithin A shows anti-atherosclerotic activity via activation of class B scavenger receptor and activation of Nef2 signaling pathway.
Topics: Angiotensin II; Animals; Aorta; Atherosclerosis; CD36 Antigens; Coumarins; Hypercholesterolemia; Lipids; Male; MAP Kinase Signaling System; NF-E2-Related Factor 2; Rats; Rats, Wistar; Receptors, Scavenger; Signal Transduction; Up-Regulation | 2018 |
Scoparone attenuates angiotensin II-induced extracellular matrix remodeling in cardiac fibroblasts.
Topics: Angiotensin II; Animals; Artemisia; Cardiomyopathies; Cell Differentiation; Cell Proliferation; Cells, Cultured; Collagen Type I; Coumarins; Extracellular Matrix; Fibroblasts; Fibronectins; Fibrosis; Myocardium; Myofibroblasts; Phytotherapy; Rats; Signal Transduction; Smad Proteins; Transforming Growth Factor beta1 | 2018 |
Caspase-11 promotes renal fibrosis by stimulating IL-1β maturation via activating caspase-1.
Topics: Angiotensin II; Animals; Caspase 1; Caspase Inhibitors; Caspases; Caspases, Initiator; Coumarins; Enzyme Activation; Extracellular Matrix; Fibrosis; Gene Silencing; Interleukin-1beta; Kidney; Kidney Diseases; Male; Mice, Inbred C57BL; Rats; RNA, Small Interfering; Ureteral Obstruction | 2019 |
Scoparone alleviates Ang II-induced pathological myocardial hypertrophy in mice by inhibiting oxidative stress.
Topics: Angiotensin II; Animals; Antioxidants; Biomarkers; Biopsy; Blood Pressure; Cardiomegaly; Collagen; Coumarins; Disease Management; Disease Models, Animal; Disease Susceptibility; Echocardiography; Fibroblasts; Immunohistochemistry; Male; Mice; Myocytes, Cardiac; Oxidative Stress; Rats | 2021 |
Activated Factor X Signaling Pathway via Protease-Activated Receptor 2 Is a Novel Therapeutic Target for Preventing Atrial Fibrillation.
Topics: Angiotensin II; Animals; Atrial Fibrillation; Factor Xa; Inflammation; Mice; Rats; Receptor, PAR-2; Rivaroxaban; Signal Transduction; Warfarin | 2021 |